CAR T-cell | International Myeloma Foundation

Dr. S. Vincent Rajkumar

Week in Review

August 6

Updated FAQs on Newly Diagnosed Multiple Myeloma for 2026 with Dr. S. Vincent Rajkumar

researchers brainstorming

Week in Review

July 30

June and July 2026: What's  New in Myeloma?

IMF conference series

Week in Review

July 16

Top Takeaways from The IMF Conference Series: Highlights from ASCO, IMWG, and EHA 2026

female scientist doing lab work

Week in Review

June 25

May and June 2026: What's New in Myeloma?

Reading data and making notes

Week in Review

May 28

April and May 2026: What's New in Myeloma?

researcher with pipette

Week in Review

April 30

March and April 2026: What's New in Myeloma? 

Top 5 CAR T-cell therapy research updates from ASH 2025

Recent News and Developments

February 18

Top 5 CAR T-cell Therapy Breakthroughs from ASH 2025

attendees of an ASH 2025 presentation

Week in Review

February 12

Dr. Joseph Mikhael's Top 10 Myeloma Abstracts from ASH 2025

Top Research at ASH 2025

Week in Review

January 22

Key Takeaways from Top Myeloma Research Presented at ASH 2025: Easy-to-Understand Insights for Patients and Care Partners

Patel Immagine-1

January 16

Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma

Top 10 myeloma breakthroughs

Recent News and Developments

January 8

CAR T & Bispecific Antibodies: The Biggest Myeloma Advances from ASH 2025

Cilta-cel Safety Enhancement

December 19

Cilta-cel Safety Enhancement: Modifiable Risk Factors for Delayed Neurotoxicity and Non-Relapse Mortality

Subscribe to CAR T-cell

Give Where Most Needed